Wang Y, Guan X. GLP-2 potentiates L-type Ca 2ϩ channel activity associated with stimulated glucose uptake in hippocampal neurons.
GLUCAGON-LIKE PEPTIDE-2 (GLP-2) is a neuropeptide secreted from endocrine cells in the gut and neurons in the brain. Through a specific G protein-coupled receptor, GLP-2R, GLP-2 stimulates intestinal crypt cell proliferation and mucosal blood flow to promote nutrient absorption while decreasing gastric emptying and gut motility to inhibit food intake (38, 58) . The GLP-2R is expressed not only in distinct gastrointestinal cells (such as enteric neurons, enteroendocrine cells, subepithelial myofibroblasts, and pancreatic ␣-cells) but also in specific regions of the central nervous system (CNS, such as the hippocampus and hypothalamus) (38, 58) . Currently, there is much interest in the central effects of GLP-1/2 in the neuroendocrine control of food intake. Besides the hypothalamus, the hippocampus is sensitive to hunger and satiety signals, thus influencing appetitive behavior through inhibitory learning and memory processes (22, 23, 67) . Moreover, neurohormonal hypothalamic circuits are integrated for the control of energy homeostasis with high-order hippocampal learning and memory processes (22) . However, the GLP-2-mediated cellular action and signaling network are largely unknown in the CNS.
Calcium entry through voltage-gated Ca 2ϩ channels (VGCC) in hippocampal neurons is important for neurotransmitter release, synaptic plasticity, gene transcription, and neuronal survival (3) . Increases in intracellular Ca 2ϩ concentrations can activate key kinases or phosphatases, which modulate ion channels, transcription factors, and regulatory proteins that are involved in synaptic plasticity and memory formation (13) . For example, Ca 2ϩ acting on the synaptic vesicle protein synaptotagmin I triggers rapid exocytosis of neurotransmitters (15, 16) . In addition, Ca 2ϩ entry through L-type VGCC induces long-term potentiation in the hippocampal pyramidal neurons, which is an important form of neuronal plasticity in learning and memory processing (61) .
The evidence that GLP-2R is expressed exclusively in these excitable cells suggests that GLP-2 signal transduction may mediate electrical activity of the plasma membrane, thus inducing neurotransmitter release from neurons and hormone secretion from endocrine cells. For example, GLP-2 stimulates glucagon secretion from pancreatic ␣-cells through unidentified molecular mechanisms (43) . Furthermore, GLP-1, coproduced with GLP-2 from neurons or endocrine cells, augments barium currents flowing through L-type VGCC through a cAMP-dependent mechanism in pancreatic ␤-cells (40, 57) . This may play a crucial role in inducing insulin secretion and neurotransmitter release. Moreover, the activity of the L-type VGCC is enhanced in neurons by cAMP-dependent protein kinase A (PKA). It is well established that GLP-2R activation increases intracellular cAMP concentration and enhances PKA-dependent signaling in hippocampal neurons (39) . However, it is unknown whether GLP-2 potentiates L-type VGCC activity in hippocampal neurons.
In the mammalian brain, ϳ50% of the total energy consumption is associated with neural signaling, including maintenance of resting potentials and neurotransmitter recycling (2, 46) . In the brain, glucose is the predominant substrate for energy metabolism. Delivery of glucose from the blood to the brain requires transport across the endothelial cells of the blood-brain barrier and the plasma membranes of neurons and glia. Previous studies show that GLP-2 enhances glucose uptake by enterocytes through promoting cellular translocation of ATP-dependent Na ϩ /glucose cotransporter 1 (17, 25) . However, it is unknown whether GLP-2 affects glucose uptake by neurons where ATP-independent, facilitative glucose transporters (such as GLUT3) are expressed. A recent study indicates that Ca 2ϩ influx is an important modulator of insulinmediated glucose uptake through Ca 2ϩ /calmodulin, which acts in GLUT4 translocation to the plasma membrane (35, 62) . Therefore, we wanted to determine whether GLP-2 facilitates glucose uptake by enhanced activity of L-type VGCC in neurons.
Our present study shows that GLP-2 potentiates the activation of L-type Ca 2ϩ channels associated with stimulated glucose uptake in primary cultured hippocampal neurons. This L-type Ca 2ϩ channel activation may play an important role in triggering neurotransmitter release and hormone secretion from GLP-2R-positive neurons and endocrine cells, respectively.
METHODS
All experiments were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. The C57BL/6J mice were fed ad libitum and given free access to water.
Localization of GLP-2R. The expression of glp2r mRNA in the mouse brain was performed by in situ hybridization (36) and quantified by an automated image processing technique (11) . The cellular distribution of glp2r mRNA abundance was denoted by a digital false-color map representing the original expression pattern, on which it was painted in yellow, blue, and red, respectively, for the weak, moderate, and strong expressions. The localization of the GLP-2R protein was confirmed by immunohistochemistry and defined on cultured hippocampal neurons by use of immunocytochemistry. Methods in details are provided in Supplementary materials (Supplementary materials are found in the online version of this paper.).
Primary culture of hippocampal neurons. Neurons were obtained from 1-day-old neonatal mice. The hippocampus was dissected in F-12 medium, digested with L15-NeurobasalA medium containing 0.1% trypsin and 0.1% DNAase at 37°C for 30 min, triturated with a pipette tip, and centrifuged at 1,000 rpm for 5 min. Dissociated cells were seeded onto slides precoated with poly-L-lysine for 30 min and cultured for 5-6 days in NeurobasalA medium supplemented with B27, 10% FBS, 10 ng/ml fibroblast growth factor-␤ (FGF␤), 0.5 mM glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 100 g/ml Primocin (Amaxa). Cytosine-␤-D-arabinofuranoside (10 M; Sigma) was added 48 h postplating to inhibit proliferation of glial cells in the primary culture.
Intact cell binding assay. To determine GLP-2-specific binding, using a modified protocol (8), we incubated primary neurons on DIV 6 in 24-well plates of 0.2 ml each with 0 -1.0 nM 125 I-labeled human GLP-2 (1-33; Phoenix Pharmaceuticals) with or without 0.5-10 M unlabeled human GLP-2 (1-33; American Peptide).
Whole cell voltage clamp. Whole cell voltage clamp recordings were performed in cultured hippocampus neurons (63) . Barium currents (I Ba) flowing through Ca 2ϩ channels were recorded using an extracellular solution containing 140 mM TEA-Cl, 2 mM MgCl2, 3 mM BaCl2, 10 mM glucose, 10 mM HEPES (pH 7.4 adjusted with TEA-OH, osmolarity 320), and a pipette solution containing 120 mM CsCl, 1 mM MgCl 2, 10 mM HEPES, 10 mM EGTA, 4 mM Mg-ATP, and 0.3 mM Na-GTP (pH 7.2 adjusted with CsOH, osmolarity 300 mOsm). 
RESULTS

GLP-2R functionally expressed in primary hippocampal neurons.
To identify spatial expression patterns of glp2r mRNA in the brain, we performed in situ hybridization at a cellular resolution. We found that the glp2r mRNA was most abundantly expressed in the hippocampus (Fig. 1A, c-f ) compared with the cortex, cerebellum, hypothalamus, and brainstem regions (data not shown), where glp2r mRNA is localized in rat and mouse brain (38, 39, 58) . This glp2r-specific expression pattern might indicate that GLP-2R plays a distinct role in the regulation of spatial metabolism and synaptic transmission. By immunohistochemistry, GLP-2R protein was expressed in the hippocampus as well (as indicated in yellow in Fig. 1B, a) . We wanted to characterize further whether the endogenous GLP-2R functionally responded to GLP-2, its native ligand. The intact cell binding assay was used to test the GLP-2 binding curve. Primary hippocampal neurons showed a saturable and specific binding to the 125 I-labeled human GLP-2 ( Fig. 2a) . By regression analysis, the specific binding at the top plateau, i.e., the maximal number of binding sites (B max ) was 1.42 fmol/mg protein and K d ϭ 0.48 Ϯ 0.05 nM, similar to a high-affinity binding (0.57 nM) of 125 I-Tyr 34 human GLP-2 1-34 in COS cells stably transfected with rat GLP-2R cDNA, which has a maximal binding at 1,839 fmol/mg protein (45) . This saturation binding indicated that the affinity of human GLP-2 for mouse endogenous GLP-2R was comparable to that of overexpressed rat GLP-2R. However, the binding site density was lower in the intact primary neurons.
Next, we wanted to test whether primary neurons acutely responded to GLP-2 treatment. c-fos, an immediate early gene widely used as a functional marker of activated neurons (33), regulates expression of target genes that can influence neuronal excitability and survival in the hippocampus (68) . Under basal condition, the c-Fos protein was expressed and localized exclusively to the nucleus in scattered neurons (Fig. 2b) . Upon GLP-2 stimulation for 30 min, the c-Fos protein was revealed not only in the nucleus but also in the cytoplasm and dendrites (Fig. 2c) , indicating c-Fos protein transient translocation from the nucleus to the cytoplasm (and dendrites) or reverse. Although the c-fos gene can be rapidly induced within 5 min and 2 h (4, 32), c-Fos protein is unstable in the cytoplasm through ubiquitin-and/or proteosome-dependent degradation pathways. This spatiotemporal regulation of c-Fos may be mediated by the GLP-2R-activated cAMP pathway (53, 55) , altering neuronal activity in the hippocampus.
GLP-2-enhnaced Ba 2ϩ currents predominately through Ltype VGCC potentiation. Because Ca 2ϩ influx can directly increase neuronal excitation through synaptic receptors and voltage-gated channels (37), we wanted to examine whether GLP-2 stimulation could modulate activity of VGCC in primary neurons. To minimize the confounding effects of Ca 2ϩ on the kinetics of VGCC, Ba 2ϩ currents (I Ba ) were recorded flowing through all subtypes of VGCC in primary neurons. Ba 2ϩ currents were recorded through a voltage step protocol (from Ϫ90 to 40 mV). The I-V curve showed reverse potentials and peaks (at ϳ40 mV) as typical values for Ba 2ϩ currents (Fig. 3A, a and b) . No shift was found in the voltage dependence of Ca 2ϩ channel activation, indicating that I Ba was increased throughout the voltage range. Moreover, the peak of the whole cell I Ba was also achieved at 0 mV. GLP-2 potentiated the whole cell I Ba in cultured hippocampal neurons (Fig.  3A , e, P Ͻ 0.01). The peak of I Ba was 139 Ϯ 13 pA for neurons under the basal condition, whereas it was 202 Ϯ 10 pA for neurons in the presence of 20 nM GLP-2, indicating that GLP-2 enhanced VGCC activity by 45%. This effect was reversed after washout of GLP-2.
L-type VGCC are predominant VGCC in hippocampal neurons. We further characterized a GLP-2-mediated increase in the peak of Ba 2ϩ inward currents flowing through L-type VGCC by isolating it electrophysiologically (at a holding potential of Ϫ40 mV shown in Fig. 3A, b, d , and f) (18, 60) ; and defined it pharmacologically using an L-type Ca 2ϩ channel blocker, nifedipine (at 10 M) (Fig. 4, a, c, and e) . Approximately 80% of the peak I Ba was attributed to GLP-2-mediated enhancement of L-type VGCC activation under the basal condition or under the stimulatory condition, indicating that the peak I Ba (reached at 0 mV) evoked at the holding potential of Ϫ40 mV was flowing substantially through L-type VGCC. Importantly, ϳ85% of peak I Ba was inhibited pharmacologically in the presence of nifedipine at 10 M, representing that recorded I Ba was mainly through L-type channels. Moreover, the peak I Ba was not increased in GLP-2-treated neurons pretreated with nifedipine. The average peak I Ba was at Ϫ15 Ϯ 10 pA for nifedipine-treated neurons and Ϫ17 Ϯ 13 pA for nifedipine-preloaded, GLP-2-treated neurons. However, after a washout procedure, it increased again (Ϫ129 Ϯ 13 pA, P Ͻ -induced inactivation of L-type VGCC. Therefore, we further analyzed the activation kinetics from the G-V curve (Fig. 3B) . The V 1/2 was at Ϫ1.06 Ϯ 0.32 mV for the controlled neurons and at Ϫ4.11 Ϯ 0.38 mV for the GLP-2-treated neurons. This was a shift (P Ͻ 0.01) toward a more hyperpolarized activation, indicating that an enhanced activation of L-type VGCC might be attributed to GLP-2-increased inward I Ba . Hyperpolarization shift in the G-V curve reflects an improved coupling between gating charge movement and channel opening.
PKA is shown to enhance activation of L-type VGCC by phosphorylating the ␣ 1C subunit (of Ca v 1.2) (20, 24) . It has been demonstrated that GLP-2 increases intracellular cAMP accumulation and enhances PKA activity in HEK cells overexpressing GLP-2R. Thus, GLP-2-induced potentiation of Ltype VGCC activation might be mediated through activating cAMP-dependent PKA signaling pathways. To assess this possibility, we tested whether GLP-2-mediated potentiation of L-type VGCC activity was attenuated in neurons pretreated with the membrane-permeable PKA inhibitor PKI 14 -22 . We found that GLP-2 treatment did not increase the peak I Ba in neurons that were preloaded with PKI 14 -22 (at 1 M) (Fig.  4, b, d, and f) . There was no difference in the peak I Ba (Ϫ64 Ϯ 8 pA for PKI 14 -22 -treated neurons and Ϫ66 Ϯ 10 pA for PKI 14 -22 -preloaded, GLP-2-treated neurons). After a washout procedure, however, the peak I Ba was increased in the presence of GLP-2 as described above.
GLP-2-mediated stimulation in glucose uptake. To determine whether hippocampal neurons directly take up glucose, we first used 6-NBDG as a fluorescent, nonhydrolyzable glucose analog to trace glucose uptake and transport (31, 64) . Neurons could directly take up and utilize glucose as energy sources in vitro (Fig. 5a) , which is in agreement with recent reports (31, 52) . Furthermore, we detected the protein expression of the facilitative glucose transporter (GLUT3) mainly responsible for neuronal glucose uptake, which may play a key role in synaptic energy supply and neurotransmitter synthesis (19) . GLUT3 (labeled in green in Fig. 5b ) was expressed not only in neurons (identified by a neuron-specific marker PGP9.5 in red), but also in glial cells. However, the abundance of GLUT3 protein did not increase in neurons after treatment with GLP-2 at 20 nM for 30 min (data not shown). These data are in agreement with reports that expression of the GLUT3 protein does not acutely increase within 3 h in neurons treated with brain-derived neurotrophic factor (6, 51) . However, we cannot rule out the possibility that acute GLP-2-stimulated glucose uptake might be attributed to subcellular translocation of GLUT3.
Moreover, we quantified whether GLP-2 modulates glucose uptake in primary neurons by the [ 3 H]2-DG uptake assay. 2-DG is a glucose analog that is transported specifically by ATP-independent, facilitative glucose transporters, but not by ATP-dependent Na ϩ /glucose cotransporters. In the presence of cytochalasin B (50 M), a competitive inhibitor of glucose transport through facilitative glucose transporters, 2-DG uptake was at 3.5%. Thus 96.5% of 2-DG uptake was cytochalasin B sensitive, mainly through facilitative glucose transportermediated uptake (Fig. 5c) . Compared with the baseline, insulin (50 nM) stimulated 2-DG uptake. Insulin regulates glucose uptake by hippocampal neurons by promoting GLUT3 translocation in the presence of 40 mM KCl (59). 2-DG uptake by primary neurons increased in a dose-dependent manner with increasing concentrations of GLP-2 ( Fig. 5d) and reached a plateau at 20 nM. We further characterized cellular mechanisms by which GLP-2 stimulated glucose uptake in primary neurons. Previous studies showed that GLP-2 activates cAMP-dependent PKA signaling to promote neuronal survival. We wanted to examine whether GLP-2-mediated stimulation of 2-DG uptake was mediated partially through the activation of cAMP-dependent PKA. Although primary neurons were preloaded with PKI 14 -22 (1 M) 30 min prior to GLP-2 treatment, GLP-2-mediated stimulation in 2-DG uptake was abolished completely by PKI 14 -21 (Fig. 6a) . To examine whether GLP-2-stimulated uptake of glucose was associated with the potentiation of L-type VGCC activity, hippocampal neurons were treated with GLP-2 in the presence of nifedipine (10 M). GLP-2-mediated stimulation on 2-DG uptake was completely blocked by nifedipine (Fig. 6b) . Moreover, the basal uptake of glucose was suppressed by the PKA inhibitor but not by the L-type VGCC blocker. (Note that the abundance of GLUT3 protein was not increased in neurons treated with GLP-2 at 20 nM for 30-min. Thus, the abundance of GLUT3 protein might not be attributed to GLP-2-acutely mediated stimulation of glucose uptake.) Together, these data indicate that GLP-mediated stimulation of glucose uptake might involve the potentitaion of L-type VGCC activity.
DISCUSSION
In the present study, we characterized functionally the primary culture model of mouse hippocampal neurons that expressed endogenous GLP-2R, and we showed that GLP-2 increased Ba 2ϩ currents through potentiated activation of Ltype Ca ϩ channels by using the whole cell voltage clamp. This potentiation was mediated by activating the cAMP-dependent PKA signaling pathway. Moreover, GLP-2 stimulated glucose uptake by primary neurons, and this stimulation was not only dependent upon activation of PKA, but also associated with potentiation of L-type Ca ϩ channels. We speculate that GLP-2-mediated potentiation of L-type Ca ϩ channel activity may play an important role in Ca 2ϩ -triggered neurotransmitter release and hormone secretion from GLP-2R-positive neurons and endocrine cells, respectively. In addition, GLP-2-mediated potentiation of L-type VGCC activity would induce long-term potentiation in the hippocampal pyramidal neurons, which may play a critical role in coupling cellular signal transduction to learning and memory (61) or neuroprotection (39) .
Characterization of endogenous GLP-2R in primary neurons. GLP-2R is expressed in endocrine cells, neurons, and myofibroblasts. GLP-2R function and signaling have been studied mainly in cell lines overexpressing the receptor, and functional expression of endogenous GLP-2R has not been characterized in primary cells. We found that GLP-2R was expressed not only in primary hippocampal neurons but was also specifically and functionally responsible for GLP-2-mediated stimulation. We were the first to characterize binding properties of endogenous GLP-2R and showed a saturated curve with the binding affinity (K d ) similar to that in GLP-2R-overexpressed membrane preparation. Moreover, subcellular translocalization of the early gene c-fos might reflect an acute GLP-2-mediated action. Therefore, this characterization of endogenous GLP-2R would validate the usefulness of working with primary cultures of hippocampal neurons in further studies of GLP-2 function and signaling.
GLP-2 potentiates activation of L-type VGCC.
One of the major findings in the present study is that GLP-2 increased the peak I Ba (by ϳ50%) flowing through VGCC, which was attributed to the potentiation of L-type VGCC activation in primary hippocampal neurons. Potentiation of the L-type subtype was concluded from the following data. 1) L-type Ca 2ϩ channels are predominantly and functionally expressed in the somatodendritic compartment of hippocampal neurons cultured for ϳ5 days (48) . Moreover, L-type Ca 2ϩ channels are functionally present in CA1 pyramidal neurons, contributing to spinal Ca 2ϩ influx (29) . 2) L-type currents in neurons are attributed mainly to the activation of Ca v 1.2 and Ca v 1.3, which are evoked within Ϫ40 to 0 mV (14) . Barium currents were recorded at a holding potential of Ϫ40 mV in voltage step protocols in the present study. 3) GLP-2-mediated potentiation was completely blocked by the L-type Ca 2ϩ channel blocker (9, 13, 14, 27) . For example, potentiation of L-type VGCC may increase Ca 2ϩ influx into hippocampal neurons, which is associated with late-phase, long-term potentiation underlying learning and memory (28, 44) .
GLP-2-mediated potentiation of L-type VGCC activity through activating PKA signaling. GLP-2 increased I Ba flowing through L-type VGCC as a result of enhanced activation of those channels indicated by a significant leftward shift in the G-V curve. Furthermore, GLP-2-mediated potentiation of Ltype VGCC activity was blocked by a PKA inhibitor, suggesting that GLP-2-mediated potentiation was dependent on activation of the PKA signaling. GLP-2 increases intracellular cAMP production by activating GLP-2R-coupled G s protein.
The cAMP-dependent PKA regulates a wide array of cellular functions, including modulating the activity of the L-type VGCC in hippocampal neurons (20, 21, 29) . L-type VGCC is composed minimally of pore-forming ␣ 1 -subunits along with accessory ␤-and ␣ 2 ␤-subunits. L-type Ca 2ϩ channel (Ca v 1.2) is associated with the G protein-coupled receptor in hippocampal neurons (20) . Importantly, the activity of Ca v 1.2 can be enhanced in hippocampal neurons by ␤-adrenergic ligands, which is mediated by PKA-dependent phosphorylation of the ␣ 1 -subunit (at Ser 1928 ) (20, 21, 24, 26, 29, 47) . Thus, we speculate that GLP-2 modulates ␣ 1 -subunit phosphorylation and facilitates L-type VGCC activation, causing a left shift in the conductance-voltage relationship and potentiating peak I Ba at hyperpolarized membrane potentials. However, we cannot exclude the possibility that suppression of the inactivation process of the L-type Ca 2ϩ channel is involved in the GLP-2-mediated increase in Ba 2ϩ currents. Glucose uptake in hippocampal neurons. In the present study, we have shown that glucose can be taken up directly by primary neurons, as indicated by the intracellular accumulation of 6-NBDG. In addition, the GLUT3 protein was highly expressed in primary neurons transporting glucose across the plasma membrane. It has been hypothesized that neurons obtain their energy source from glial lactate, especially during neuronal activation (56) . However, this concept is challenged by a recent model that indicates that the neuron is the primary site of glucose uptake and utilization under both steady-state and stimulated conditions (56) . Neuronal uptake of glucose is mediated by facilitative glucose transporters such as GLUT3 (19, 41) . Insulin promotes GLUT3 translocation to the plasma membrane, enabling neurons to respond to energy demand induced by increased neuronal activity (59) . However, glucose transport (via GLUT3) is largely independent of insulin in the CNS (42) . In neurons, phosphorylated CREB (cAMP regulatory element-binding) can bind the glut3 gene, trans-activating its expression (49) . However, we could not find any increase in the abundance of GLUT3 protein or subcellular translocation of GLUT3 protein in hippocampal neurons treated with GLP-2 for 30 min. We cannot exclude the involvement of other isoforms (e.g., GLUT1, -4, and -8) in GLP-2-mediated stimulation of glucose uptake. We speculate that insulin-stimulated glucose uptake in the present study might be attributed to insulin-responsive GLUT4 and -8 that are also expressed in hippocampal neurons (1, 5, 10, 50, 54) . The novel role of GLP-2-stimulated glucose uptake in neurons might be important, since cellular glucose uptake is predominantly insulin independent in the brain. Further studies are warranted to confirm which isoforms of facilitative glucose transporters in neurons are specifically regulated by GLP-2.
Another major finding in the present study is that GLP-2-mediated stimulation of glucose uptake was involved with the potentiation of L-type VGCC activation in primary neurons. Previous studies suggest that Ca 2ϩ influx through L-type VGCC is involved in insulin-stimulated glucose transport in skeletal muscle (66) . Thus, we hypothesized that GLP-2-mediated enhancement of Ca 2ϩ channel activity would alter glucose uptake in neurons. Interestingly, GLP-2-mediated stimulation of glucose uptake was completely blocked in the presence of nifedipine, an L-type Ca 2ϩ channel inhibitor, suggesting that this metabolic action is mediated partially by enhanced L-type Ca 2ϩ channel activity. Recent studies show that increased influx of Ca 2ϩ across the plasma membrane is associated with insulin-mediated increase in glucose uptake (34, 35) , possibly through facilitating docking, fusion, and/or insertion of GLUT4 in the membrane via Ca 2ϩ sensor (such as synaptotagmin I) in the neurons (34, 35, 62) or through modulating calcium-calmodulin-dependent kinase II signaling (30) . However, nifedipine did not affect the basal level of 2-DG uptake. This is in agreement with studies that a solitary decrease in Ca 2ϩ influx is not enough to alter basal glucose uptake (12, 35, 62) .
The novel function of GLP-2-mediated potentiation of Ltype Ca ϩ channel activity might be physiologically relevant to its neuroendocrine modulation of neurotransmitter release and hormone secretion. As mentioned previously, it is assumed that GLP-2 executes cellular actions and metabolic effects mainly through secondary mediators such as neurotransmitters (e.g., nitric oxide, serotonin, and vasoactive intestinal peptide) and hormones (e.g., glucagon, IGF-I, and KGF). GLP-2-mediated enhancement of L-type Ca ϩ channel activity would increase cellular Ca 2ϩ influx, resulting in Ca 2ϩ -triggered release of neurotransmitters and secretion of hormones. Moreover, GLP-2-mediated potentiation of L-type Ca ϩ channel activity would induce long-term potentiation, which is highly relevant to key functions (e.g., learning and memory) of the hippocampus. Finally, GLP-2-stimulated uptake of glucose might be equally relevant to energetic demand for neuronal activities and regulation of glucose metabolism in the brain. This regulatory process might be physiologically important, because uptake and utilization of glucose in the brain is insulin independent. However, further studies are warranted to define physiological significance of GLP-2-mediated neuronal action and signaling by using neuron-specific GLP-2R deficiency mouse models.
In summary, we showed that GLP-2-mediated potentiation of L-type Ca 2ϩ channel activity was mediated through the activation of PKA. GLP-2-mediated stimulation of glucose uptake was not only dependent upon activation of PKA, but also coupled with potentiated activation of L-type Ca 2ϩ channels. GLP-2-potentiated activation of L-type Ca 2ϩ channels may be physiologically relevant to neurotransmitter release, synaptic plasticity, and energetic demand for memory forma-tion in the hippocampus. However, further studies are warranted to establish whether GLP-2-potentiated activation of L-type Ca 2ϩ channels initiates Ca 2ϩ -triggered neurotransmitter release and hormone secretion from GLP-2R-positive neurons and endocrine cells and to define whether GLP-2R activation modulates phosphorylation of ␣ 1 -subunits of L-type VGCC in those cells.
